hpNSC (International Stem Cell/Rohto)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamehpNSC (International Stem Cell/Rohto)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInternational Stem Cell Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInternational Stem Cell CorpRohto Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A